This report has 3 mentions of increasing shareholder value. The same hollow talk that followed the sale of the zinc lease.
Since then the share price has gone down close to a 12 month low & the $15 mil has reduced to $12 mil.
Draw your own conclusions as to who the beneficiaries are here. It certainly is not the ordinary shareholders.
I would like to see these directors starting to buy their own shares off the market to boost the SP.
This would at least show that they believe in their own future predictions for the company going forward.
- Forums
- ASX - By Stock
- RXL
- Ann: 2018 Exploration Strategy
Ann: 2018 Exploration Strategy, page-2
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RXL (ASX) to my watchlist
(20min delay)
|
|||||
Last
13.5¢ |
Change
0.005(3.85%) |
Mkt cap ! $57.48M |
Open | High | Low | Value | Volume |
13.0¢ | 13.5¢ | 13.0¢ | $38.48K | 285.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 77428 | 13.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
14.0¢ | 214871 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 6539315 | 0.008 |
15 | 12069642 | 0.007 |
5 | 2958583 | 0.006 |
5 | 3098180 | 0.005 |
3 | 1255003 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 1924318 | 1 |
0.010 | 1406625 | 6 |
0.011 | 888479 | 5 |
0.012 | 621646 | 2 |
0.013 | 1000000 | 2 |
Last trade - 14.59pm 27/09/2024 (20 minute delay) ? |
RXL (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
Previous Video
Next Video
SPONSORED BY The Market Online